MIWG was formed in 2006 to seek clarity in the FDA regulatory scheme regarding the dissemination of truthful non-misleading information about prescription drugs, biological products and medical devices, and to improve the federal regulatory framework and enforcement climate affecting manufacturer dissemination of information regarding those products (including products in development and new uses of marketed products).
Resources
FDA Submissions and Amicus Briefs Filed on Behalf of MIWG Members.
March 1, 2023
July 28, 2021
July 28, 2021
November 21, 2019
January 23, 2019
December 17, 2018
February 5, 2018
December 7, 2017
November 14, 2017
July 18, 2017
April 19, 2017
November 9, 2016
November 24, 2015
October 31, 2014
October 31, 2014
September 16, 2014
September 16, 2014
August 25, 2014
May 2, 2014
April 14, 2014
September 3, 2013
March 27, 2012
July 5, 2011